Primary liver cell carcinoma occur predominantly in patients with chronic hepatitis B virus infection. Tumours occur late in the disease, usually after cessation of detectable viral replication and at a stage when the liver contains clones of cells containing integrated HBV DNA. 1 These cells display hepatitis B surface (HBs) antigen in the cytoplasm and in small amounts in association with the cell membrane.
Only a minority of patients with primary liver cell carcinoma are suitable for surgical resection and the remainder show a poor response rate to cytotoxic therapy including adriamycin.2 The demonstration of virus coded and tumour specic antigens (in preparation) on these virus induced tumour cells has led investigators to believe that immunotherapy may be possible.
Initially, hetero-antisera to tumour specific antigens were used for cytotoxic therapy but more recently attempts have been made to raise monoclonal antibodies to these determinants and to conjugate these with plant toxins, thereby creating potent tumoricidal systems. In this paper, we have evaluated the effect of native and ricin conjugated monoclonal antibody to HBs antigen on the in vitro growth of the Alexander primary hepatocellular carcinoma cell line (PLC/PRF/5). Because Ricin was conjugated to the purified antibody (RF-HBs-1) using a mixed anhydride derivative of chlorambucil as the coupling agent.7 As a control, normal non-immune horse globulin (NHG) was conjugated to ricin by the same procedure. The globulin/ricin ratio was similar in both conjugates.
IN VITRO CYTOTOXICITY ASSAY
The cytotoxicity studies conducted in vitro utilised PLC/PRF/5 cells, harvested in logorythmic growth. The cells were suspended in normal growth medium at 2.5 x 104 cells/ml and 200 ,ul aliquots were dispensed into flat bottomed microtitre plates. The cells were incubated for 22 hours at 37°C in a humidified 95% air, 5% CO2 atmosphere and then 25 gl of either RF-HBs-1 ricin, NHG ricin or saline were added. The cells were incubated for a further 22 to 30 hours and 1 gCi of tritiated leucine added to each well. The cultures were then harvested at two, four, six or eight hours after addition of the leucine. The cells were washed and harvested by mild trypsinisation followed by aspiration on to glass fibre discs by means of a Titretek cell harvester (Flow Laboratories Ltd). The discs were air dried and bound radioactivity counted. 4 (Fig. 1) . This effect was seen at 2 hours (Fig. 2) . There was no change in leucine uptake in the presence of anti-HBs or saline. The inhibitory effect of the NHG ricin was considerably less than that of native ricin. The anti-HBs ricin conjugate, however, exhibited an increased cytotoxicity above that of the normal human globulin ricin conjugate. The anti-HBs ricin and non-immune globulin ricin conjugates exhibited similar toxicity for peripheral blood mononuclear cells obtained from non-infected patients. In this system, ricin once again showed a greater level of toxicity (Fig. 3 ). 
EFFECTS OF ANTI-HBS AND ANTI-HBS RICIN CONJUGATES ON PRIMARY LIVER CARCINOMA GROWTH IN ATHYMIC MICE
Animals injected with 500 ug of ricin intravenously at weekly intervals died within three weeks. Animals receiving either normal horse globulin ricin (eqivalent of 500 ,g of ricin intravenously weekly) or saline, survived for between four and six weeks. Over this time the tumour increased in diameter and the serum alphafetoprotein concentrations rose exponentially (Figs. 4, 5 After several weeks, however, whereas the animals given native anti-HBs showed a more rapid growth of the tumour, the animals receiving ricin conjugated anti-HBs continued to exhibit a slower rate of growth. These studies raise some interesting possibilities regarding the pathogenesis of primary liver cell cancer. It now seems clear that hepatocytes containing integrated HBV-DNA but not replicating HBV particles, are present during the late phase of the infection.'3 14 Recovery necessitates inhibition of viral replication and lysis of cells containing integrated HBV-DNA. It now seems probable that different immune mechanisms are responsible for each of these processes. 15 In many i Hbs and patients with chronic HBV infection, virus replicaing nude tion ceases within the first few years of infection, presumably because of elimination of hepatocytes containing replicating virus. The majority of these patients remain HBs antigen positive because of the onoclonal presence of residual clones of hepatocytes activity in containing HBV-DNA and secreting HBs antigen. oes not fix It is probable that malignant transformation occurs e that the in this population of cells and gives rise to primary c mice, is liver cell cancer. The PLC/PRF/5 cell line contains . It seems the integrated hepatitis B viral genome but does not th may be replicate the intact virus. In this respect, it is similar dependent to the clones of cells which give rise to the tumour in man. Our demonstration that the growth of these seeds of a primary liver carcinoma cells may be inhibited by protein of antibody to HBs suggests that their continuing :h consists growth in vivo may be related to a relative deficiency in and a of the immune response to this particular antigen in disulphide those patients who develop HBs antigen secreting te residues primary liver carcinoma. In this respect it is of n binds to interest that the fathers of patients with primary tion of the liver cell cancer show a defective immune response apable of to HBs antigen suggestin6 a possible hereditary on of 60S specific immune deficiency. 6 Other mechanisms by ely potent which virus transformed cells may evade the kill a cell. immune surveillance system include failure to its B chain display a virus encoded antigen'7 or non-association the non-of viral antigens with the HLA determinants.18 nd confers
In this study we have shown that anti-viral hat of the antibodies may inhibit the growth of a virus induced the ricin tumour. This effect is evident when the tumour is toxicity for already well established and may offer some noma cells potential for the therapy of primary liver cell ,ates were carcinoma. 
